• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Why are BI oncology reps paid more than the rest of the company?

Quote












Yes! AK! The question remains, why would this dolt be interviewing like crazy with other companies, when he has the most cush job with no responsibility? I think I know who may have it out for him... just speculating though.
 




My goodness. You people are really mean. It takes a lot of courage to make fun of people behind your keyboard. Don’t you think he has come a long way? I remember when he came to one of our breakout sessions and tried to explain what he does. He was really cute and really nervous. It was funny how many times he said “ya know” in a sentence. It was like watching an post-game NBA interview. I tried to make eye-contact with him, but he kept looking down and shuffled his feet. He knew what I was up to. Someone said his better half was on the heavy side too which makes me think I have a chance. Not sure if he plays around at meetings like some of his superiors, but I sure want to find out.
 




Ward used to do an impression of him that was “spot on”

anonymous said:
My goodness. You people are really mean. It takes a lot of courage to make fun of people behind your keyboard. Don’t you think he has come a long way? I remember when he came to one of our breakout sessions and tried to explain what he does. He was really cute and really nervous. It was funny how many times he said “ya know” in a sentence. It was like watching an post-game NBA interview. I tried to make eye-contact with him, but he kept looking down and shuffled his feet. He knew what I was up to. Someone said his better half was on the heavy side too which makes me think I have a chance. Not sure if he plays around at meetings like some of his superiors, but I sure want to find out.
Click to expand...
 




anonymous said:
Don't kid yourself. I am in oncology and can barely see a doctor. The drug we sell is viewed as a "dog" in the industry. It's used primarily in the salvage setting for a subgroup of patients who have nothing else to turn to. I basically call on nurses who are reluctant to give up their time and do lunches where I can. We are overpaid and we know it. How we get paid so much more than you is a mystery to me. Sorry about that, but it's just the way it is. Hopefully you can find an opportunity in oncology, but my advice would be to get the job with a real company. The self-absorbed leadership here has the false impression that they are "players" in the industry. Far, far, from the truth.
Click to expand...

Truth, BI Onc is the laughing stock of the industry. If one of the pipeline drugs makes it to market this bunch of oncology rejects will surely fail the company and the patients that deserve better....again
 




BI Oncology is the sweet spot of The company
Yes several people with onc experience have been at other companies
To refer to these elite professionals as losers is only a sign of envy. They overcome access obstacles and achieve their sales goals for the company.
It takes tenacity to work in this field which most of the primary care reps do not understand
 




anonymous said:
BI Oncology is the sweet spot of The company
Yes several people with onc experience have been at other companies
To refer to these elite professionals as losers is only a sign of envy. They overcome access obstacles and achieve their sales goals for the company.
It takes tenacity to work in this field which most of the primary care reps do not understand
Click to expand...
 








How can you argue that oncology is not the sweet spot? For example, look at the fella the previous posts were referring to. Perfect example of a person overpaid and under qualified. Produces nothing, and continues to thrive in the organization. We are untouchable in this organization.
 
























I left this p.o.s. “Oncology” company over a year ago to join a small oncology biotech. How you are all still a division amazes me. The leadership, and product are a joke. AK, the person I think you are referring to in this thread, is probably the most useless person I have ever encountered in 15 years of oncology. Is he in fact, still employed? Y’all need to get the hell out.
 
















Top Bottom
Back
Quote